UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects

Gynecological endocrinology, 1996, Vol.10 (3), p.207-218

Lachnit-Fixson, U.

1996

Volltextzugriff (PDF)

Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: A randomized, controlled trial

Contraception (Stoneham), 1993-10, Vol.48 (4), p.291-301

1993

Volltextzugriff (PDF)

Schlußbemerkung

Antiandrogen-Östrogentherapie bei Androgenisierungserscheinungen, 2019, p.252-252

Originally published 1987, 2019

Volltextzugriff (PDF)

Antiandrogen-Estrogen Therapy for Signs of Androgenization

2019

Volltextzugriff (PDF)

The Development and Evaluation of An Ovulation Inhibitor (Diane®) Containing An Antiandrogen

Acta obstetricia et gynecologica Scandinavica, 1979, Vol.58 (S88), p.33-42

Lachnit-Fixson, U.

1979

Volltextzugriff (PDF)

Inhibition of ovulation by a triphasic gestodene-containing oral contraceptive

Advances in contraception, 1993-09, Vol.9 (3), p.187-194

1993

Volltextzugriff (PDF)

Closing remarks

Antiandrogen-Estrogen Therapy for Signs of Androgenization, 2019, Vol.3, p.242-242

Originally published 1987, 2019

Volltextzugriff (PDF)

Extended clinical studies on a new biphasic preparation

Therapie der Gegenwart, 1974-09, Vol.113 (9), p.1486

Lachnit, U

1974

Volltextzugriff (PDF)

Triphasic combination of ethinyl estradiol and gestodene long-term clinical trial

Contraception (Stoneham), 1992-07, Vol.46 (1), p.19-27

1992

Volltextzugriff (PDF)

Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans

Arzneimittel-Forschung, 1973-06, Vol.23 (6), p.779

1973

Volltextzugriff (PDF)

Persistence of Isoconazole in Vaginal Secretion after Single Application: Verweildauer von Isoconazol im Vaginalsekret nach einmaliger Applikation

Mycoses, 1984-02, Vol.27 (2), p.97-101

1984

Volltextzugriff (PDF)

Persistence of Isoconazole in Vaginal Secretion after Single Application

Mycoses, 1984-02, Vol.27 (2), p.97-101

1984

Volltextzugriff (PDF)

Treatment of hormonally induced bleeding abnormalities and psychovegetative disorders with a two-phase preparation

Therapie der Gegenwart, 1974-02, Vol.113 (2), p.254

1974

Volltextzugriff (PDF)

Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon (author's transl)

Medizinische Klinik, 1977-11, Vol.72 (45), p.1922

1977

Volltextzugriff (PDF)

Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane

Fortschritte der Medizin, 1986-07, Vol.104 (27-28), p.547

1986

Volltextzugriff (PDF)

New approaches to interception--postcoital use of a gestagen/estrogen combination

Geburtshilfe und Frauenheilkunde, 1986-11, Vol.46 (11), p.846-848

Lachnit-Fixson, U

1986

Volltextzugriff (PDF)

Progress in oral contraception. Advantages of a levonorgestrel-containing 3-stage preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations

Fortschritte der Medizin, 1984-09, Vol.102 (33), p.825

Lachnit-Fixson, U

1984

Volltextzugriff (PDF)

Diane--a gestagen-estrogen combination with antiandrogenic effect

Medizinische Monatsschrift, 1977-09, Vol.31 (9), p.425

1977

Volltextzugriff (PDF)

New cycle-stabilizing contraceptive agent (Ediwal)

Medizinische Monatsschrift, 1976-07, Vol.30 (7), p.317

1976

Volltextzugriff (PDF)

60 years of steroid hormone research

MMW, Munchener medizinische Wochenschrift, 1983-09, Vol.125 (36), p.757

1983

Volltextzugriff (PDF)

The development and evaluation of an ovulation inhibitor (DIAne) containing an antiandrogen

Acta obstetricia et gynecologica Scandinavica. Supplement, 1979, Vol.88, p.33

Lachnit-Fixson, U

1979

Volltextzugriff (PDF)

Persistence of isoconazole in vaginal secretion after single application

Mykosen (Berlin), 1984-02, Vol.27 (2), p.97

1984

Volltextzugriff (PDF)

The first three-stage preparation for hormonal contraception. Clinical results (author's transl)

MMW, Munchener medizinische Wochenschrift, 1979-10, Vol.121 (43), p.1421

Lachnit-Fixson, U

1979

Volltextzugriff (PDF)

Lifestyle of sponge symbiont phages by host prediction and correlative microscopy

The ISME Journal, 2021-07, Vol.15 (7), p.2001-2011

2021

Volltextzugriff (PDF)

Contraceptive efficiency of triphasic inhibitors (author's transl)

Medizinische Klinik, 1977-12, Vol.72 (48), p.2081

1977

Volltextzugriff (PDF)

1 – 25 von 31

Menü

Weitere Dienste

Einstellungen

The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects

Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: A randomized, controlled trial

Schlußbemerkung

Antiandrogen-Estrogen Therapy for Signs of Androgenization

The Development and Evaluation of An Ovulation Inhibitor (Diane®) Containing An Antiandrogen

Inhibition of ovulation by a triphasic gestodene-containing oral contraceptive

Closing remarks

Extended clinical studies on a new biphasic preparation

Triphasic combination of ethinyl estradiol and gestodene long-term clinical trial

Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans

Persistence of Isoconazole in Vaginal Secretion after Single Application: Verweildauer von Isoconazol im Vaginalsekret nach einmaliger Applikation

Persistence of Isoconazole in Vaginal Secretion after Single Application

Treatment of hormonally induced bleeding abnormalities and psychovegetative disorders with a two-phase preparation

Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon (author's transl)

Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane

New approaches to interception--postcoital use of a gestagen/estrogen combination

Progress in oral contraception. Advantages of a levonorgestrel-containing 3-stage preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations

Diane--a gestagen-estrogen combination with antiandrogenic effect

New cycle-stabilizing contraceptive agent (Ediwal)

60 years of steroid hormone research

The development and evaluation of an ovulation inhibitor (DIAne) containing an antiandrogen

Persistence of isoconazole in vaginal secretion after single application

The first three-stage preparation for hormonal contraception. Clinical results (author's transl)

Lifestyle of sponge symbiont phages by host prediction and correlative microscopy

Contraceptive efficiency of triphasic inhibitors (author's transl)

Aktive Filter

Suchergebnisse filtern